People

Takehiko Nomura

Takehiko Nomura is a pharmaceutical executive whose published FrontAct biography describes a Kyoto doctorate, drug-development and CMC work, and leadership of Sumitomo Pharma’s global frontier business. He became FrontAct chief executive in 2024; subsequent ownership changes are separate from his earlier Sumitomo career. BehaVR’s 2020 SEC filing identifies him as a director, corroborated by his published professional profile. Only that historical BehaVR directorship is represented here.